アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
A synthetic peptide corresponding to residues near the C terminus of Human Mesothelin.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
This antibody detects full-length Mesothelin precursor (69 kDa) and the C terminal cleaved form of Mesothelin.
Our Abpromise guarantee covers the use of ab92347 in the following tested applications.
|WB||1/1000 - 1/10000. Predicted molecular weight: 69 kDa.Can be blocked with Mesothelin peptide (ab134675).|
ab92347 has not yet been referenced specifically in any publications.